Learn how we can build together a resilient path for CM patients and families.

CMatter Policy Recommendations for the 2024-2029 EU Mandate

New Infographic: Why EU Cardiovascular Policies Must Tackle Cardiomyopathies 

We are excited to introduce CMatter’s latest infographic, EU Cardiovascular Disease Policies Must Tackle Cardiomyopathies, which highlights the need to give greater attention to cardiomyopathies in European cardiovascular policies. 

Key Recommendations 

The infographic proposes policy recommendations focusing on: 

  • Promoting early diagnosis through screening and genetic counseling
  • Ensuring and promote access to expert care   
  • Supporting patients and their families
  • Advancing research
  • Raising public awareness  

How the Infographic Can Help? 

This infographic provides policymakers with short, clear and practical insights into the risks of cardiomyopathies and the urgent need for targeted measures. It’s a useful tool for shaping a stronger EU cardiovascular health strategy.

Why Cardiomyopathies Need EU-Level Action? 

Cardiomyopathies affect 1.5 million people across Europe, leading to serious, and sometimes fatal, health consequences like sudden cardiac death and heart failure. Despite their prevalence and societal impact, these conditions remain largely underrecognized among cardiovascular diseases, which cost the EU €282 billion annually. 

You can download the infographic here.

Scroll to Top